As a leader in molecular diagnostics, Abbott is committed to exploring new clinical frontiers through the development and delivery of innovative systems and assay solutions that aid in the diagnosis of diseases, selection of appropriate therapies and monitoring of disease recurrence at the molecular level.Our expanding portfolio in the area of Oncology brings your molecular laboratory multiple technology and platform options.
Detection of genetic aberrations in solid tumors with DNA fluoresent in situ hybridization (FISH) probe technology is a powerful means to guide more confident diagnoses and treatment decisions. The RealTime brand is the cornerstone of Abbott Molecular's real-time polymerase chain reaction (PCR) technology. RealTime products offer a powerful combination of advanced science assays and automation systems designed to increase confidence in patient's laboratory results. Molecular testing is making personalized medicine a reality and empowering physicians to improve patient care.